Advanced search
Publication Cover
Research and Reports in Urology Volume 11, 2019 - Issue
Submit an article Journal homepage
272
Views
7
CrossRef citations to date
0
Altmetric
Review

New Implantable Tibial Nerve Stimulation Devices: Review of Published Clinical Results in Comparison to Established Neuromodulation Devices

Justine Yamashiro1 School of Medicine, Texas Tech University Health Science Center, Lubbock, TX, USAORCID Iconhttps://orcid.org/0000-0002-1900-2642
ORCID Icon,
Werner de Riese2 Department of Urology, Texas Tech University Health Science Center, Lubbock, TX, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1963-2334
ORCID Icon &
Cornelia de Riese3 Department of Obstetrics and Gynecology, Texas Tech University Health Science Center, Lubbock, TX, USA
Pages 351-357 | Published online: 23 Dec 2019

References

  • Reynolds WS, Fowke J, Dmochowske R. The burden of overactive bladder on US public health. Curr Bladder Dysfunct Rep. 2016;11(1):8–13. doi:10.1007/s11884-016-0344-927057265
  • Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guidline amendment 2019. J Urol. 2019;202:1–6. doi:10.1097/JU.0000000000000309
  • Sukhu T, Kennelly MJ, Kurpad R. Sacral neuromodulation in overactive bladder: a review and current perspectives. Res Rep Urol. 2016;8:193–199. doi:10.2147/RRU.S8954427822462
  • de Wall LL, Heesakkers JPFA. Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome. Res Rep Urol. 2017;9:145–157. doi:10.2147/RRU.S12498128861404
  • van Breda HMK, Martens FMJ, Tromp J, Heesakkers JPFA. A new implanted posterior tibial nerve stimulator for the treatment of overactive bladder syndrome: 3-month results of a novel therapy at a single center. J Urol. 2017;198:205–210. doi:10.1016/j.juro.2017.01.07828189576
  • Heesakkers JPFA, Digesu GA, van Breda J, Van Kerrebroeck P, Elneil S. A novel leadless, miniature implantable tibial nerve neuromodulation system for the management of overactive bladder complaints. Neurourol Urodyn. 2018;37:1060–1067. doi:10.1002/nau.2340128892221
  • MacDiarmid S, Staskin DR, Lucente V, et al. Feasibility of a fully implanted, nickel sized and shaped tibial nerve stimulatory for the treatment of overactive bladder syndrome with urgency urinary incontinence. J Urol. 2019;201:1–6. doi:10.1016/j.juro.2018.10.017
  • Greenberg DR, Syan R, Young-Lin N, Comiter CV, Enemchukwu K. Outcomes of sacral nerve stimulation for treatment of refractory overactive bladder among octogenarians. Neuromodulation. 2019. doi:10.1111/ner.12981
  • Truzzi J, Gomes CM, Bezerra CA, et al. Overactive bladder-18 years-part I. Int Braz J Urol. 2016;42:188–198. doi:10.1590/S1677-5538.IBJU.2015.036527176184
  • Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation within InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230. doi:10.1002/nau.2254424415559
  • Abello A, Das AK. Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects. Ther Adv Urol. 2018;10(5):165–173. doi:10.1177/175628721875608229623108
  • Tutolo M, Ammirati E, Van der Aa F. What is new in neuromodulation for overactive bladder? Eur Urol Focus. 2018;4:49–53. doi:10.1016/j.euf.2018.04.01929773501
  • Janssen DAW, Martens FMJ, de Wall LL, van Breda HMK, Heesakkers JPFA. Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives. Med Devices. 2017;10:109–122. doi:10.2147/MDER
  • Noblett K, Benson K, Kreder K. Detailed analysis of adverse events and surgical interventions in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients. Neurourol Urodyn. 2017;36:1136–1139. doi:10.1002/nau.2307627491027
  • Salatzki J, Liechti MD, Spanudakis E, et al. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the over active bladder. BJU Int. 2019;123(5A):E20–E28. doi:10.1111/bju.2019.123.issue-5A30552801
  • He Q, Xiao K, Peng L, et al. An effective meta-analysis of magnetic stimulation therapy for urinary incontinence. Sci Rep. 2019;9:9077. doi:10.1038/s41598-019-45330-931235706
  • van der Pal F, van Balken MR, Heesakkers JPFA, et al. Implant-driven tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: 12-month follow-up. Neuromodulation. 2006;9:163–171. doi:10.1111/j.1525-1403.2006.00056.x22151641
  • Hsiao SM, Lin HH, Kuo HC. Factors associated with therapeutic efficacy of intravesical onatotulinumtoxinA injection for overactive bladder syndrome. PLoS One. 2016;11(1):e0147137. doi:10.1371/journal.pone.014713726824901
  • Muhlstadt S, Mischner S, Kranz J, et al. Quo vadis botulinum toxin: normative constraints and quality of life for patients with idiopathic OAB? Front Surg. 2018;5:61. doi:10.3389/fsurg.2018.0006130386782
  • Tubaro A, Puccini F, De Nunzio C. The management of overactive bladder: percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin? Curr Opin Urol. 2015;25:305–310. doi:10.1097/MOU.000000000000018026049873

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.